US Patent Litigations are now available. Check here

EP2941251

AROG PHARMACEUTICALS
Application Number
EP13869984A
Filing Date
Oct 14, 2013
Status
Granted And Under Opposition
Feb 2, 2018
Grant Date
Mar 7, 2018
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP2941251B1 was granted on Mar 7, 2018 by Arog Pharmaceuticals . The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HEXAL PHARMADec 7, 2018ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents